Finland· FI-REL-REL7914
B.A.L.
A dimercaprol product, registered in Finland by Boots Healthcare International. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dimercaprol is registered in 4 of 19 countries.
Countries holding a registration under ATC V03AB09 (dimercaprol), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Dimercaprol · ATC V03AB09
4 / 19 countries
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Manufacturer
- Boots Healthcare International
- Country
- Finland (FI)
- ATC code
- V03AB09
- ATC class
- Dimercaprol
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for dimercaprol.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimercaprol · interactions on record
7 records
- 7 severe
Most severe, free to view
- Sodium seleniteA12CE02severe
- Ferrous fumarateB03AA02severe
- Ferrous gluconateB03AA03severe
- Ferrous sulfateB03AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AB09
Dimercaprol, as other registers publish it.
- NorwayDimavalHeyl
- NorwayDimavalHeyl
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesAdvanz Pharma
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesAlliance Healthcare (Distribution) Ltd
- Japanジメルカプロール
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d0715c6-750c-41cf-bc77-67932a40f1d4 GET /v1/drugs/5d0715c6-750c-41cf-bc77-67932a40f1d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste",
"route": null,
"ddd_unit": null,
"strength": "50 mg/ml",
"atc_label": "dimerkaproli",
"ma_number": "5021",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7914",
"authorised_at": "1967-11-01"
}See everything about dimercaprol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.